SCHEMBL20847698

SCHEMBL20847698

Cc1ccc2c(F)ccnc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 4/20 0.54
ADRA1D P25100 4/20 0.54
ADRA1A P35348 4/20 0.54
ADRA1B P35368 4/20 0.54
ALDH1A1 P00352 2/20 0.46
CHEK1 O14757 1/20 0.44
PARP1 P09874 1/20 0.44
PIM1 P11309 1/20 0.44
RPS6KA3 P51812 1/20 0.44
UHRF1 Q96T88 1/20 0.40
CCR1 P32246 1/20 0.40
CCR5 P51681 1/20 0.40
CCR8 P51685 1/20 0.40
FERMT2 Q96AC1 1/20 0.38
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL873159 0.79 HTR1A (0.58) HTR1AADRA1DADRA1AADRA1BALDH1A1
SCHEMBL19878153 0.76 ALK (0.50) FERMT2MEN1KMT2ALMNAMAPT
SCHEMBL4355081 0.76 NR4A2 (0.61) CCR1FERMT2MEN1KMT2AMAPT
SCHEMBL13632508 0.76 GAK (0.42) HTR1AADRA1DADRA1AADRA1BPARP1
SCHEMBL317506 0.76 HTR1A (0.54) HTR1AADRA1DADRA1AADRA1BALDH1A1
SCHEMBL20427414 0.76 HTR1A (0.54) HTR1AADRA1DADRA1AADRA1BALDH1A1
SCHEMBL2658022 0.76 HTR1A (0.54) HTR1AADRA1DADRA1AADRA1BALDH1A1
SCHEMBL31452673 0.76 NR4A2 (0.61) HTR1AADRA1DADRA1AADRA1BALDH1A1
SCHEMBL3071029 0.76 NR4A2 (0.61) HTR1AADRA1DADRA1AADRA1BALDH1A1
SCHEMBL5543680 0.76 HTR1A (0.54) HTR1AADRA1DADRA1AADRA1BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019056120-A1 PENTAFLUOROPHENYL SULFONAMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF DALRIADA THERAPEUTICS INC. (CA) 2019-03-28 WO disclosed